Subsequent Events	3 Months Ended
Mar. 31, 2021
Subsequent Events [Abstract]
Subsequent Events	19. Subsequent Events The Company has evaluated subsequent events through June 14, 2021, the date that financial statements were issued. On April 30, 2021, the Company’s board of directors declared a special dividend payable on May 4, 2021 to the holders of record of all issued and outstanding shares of common stock as of the close of business on May 4, 2021, in the amount of 29.5 shares of common stock for each share of common stock then outstanding. The accompanying financial statements and related notes and schedules to the financial statements give retroactive effect to the stock split for all periods and as of all dates presented. On April 30, 2021, the Company’s board of directors approved a change in the par value of the Company’s common stock from $0.10 to $0.01. This change will be reflected on the Company’s June 30, 2021 financial statements. On May 11, 2021 the Company completed its initial public offering, in which it issued and sold 3,690,000 shares of common stock at $14.00 per share, resulting in net proceeds of $48.0 million after deducting underwriting discounts and commissions. On June 4, 2021, the underwriters exercised their option to purchase an additional 115,925 shares of the Company’s common stock at the public offering price of $14.00 per share, resulting in additional gross proceeds of approximately $1.6 million. After giving effect to this partial exercise of the overallotment option, the total number of shares sold by Bowman in its initial public offering increased to 3,805,925 shares and gross proceeds increased to approximately $53.3 million. The exercise of the over-allotment option closed on June 8, 2021, at which time the Company received net proceeds of approximately $1.5 million after underwriting discounts and commissions. See Initial Public Offering in Note 1 for further details. On January 1, 2021 the Company entered into an agreement with a current employee that contained put options for 47,348 shares of common stock at $12.80 per share in increments of 7,021 shares quarterly, commencing on February 15, 2021. The option expired 90 days post-closing of an IPO. These shares were classified as common shares subject to repurchase on the condensed consolidated balance sheet as of March 31, 2021. On May 15, 2021, the employee exercised the option to redeem 1,800 shares. Based on the closing of the IPO, the option expires prior to August 15, 2021, and as such, no future option tranches may be exercised.

Subsequent Events

3 Months Ended

Mar. 31, 2021

19. Subsequent Events

The Company has evaluated subsequent events through June 14, 2021, the date that financial statements were issued.

On April 30, 2021, the Company’s board of directors declared a special dividend payable on May 4, 2021 to the holders of record of all issued and outstanding shares of common stock as of the close of business on May 4, 2021, in the amount of 29.5 shares of common stock for each share of common stock then outstanding. The accompanying financial statements and related notes and schedules to the financial statements give retroactive effect to the stock split for all periods and as of all dates presented.

On April 30, 2021, the Company’s board of directors approved a change in the par value of the Company’s common stock from $0.10 to $0.01. This change will be reflected on the Company’s June 30, 2021 financial statements.

On May 11, 2021 the Company completed its initial public offering, in which it issued and sold 3,690,000 shares of common stock at $14.00 per share, resulting in net proceeds of $48.0 million after deducting underwriting discounts and commissions. On June 4, 2021, the underwriters exercised their option to purchase an additional 115,925 shares of the Company’s common stock at the public offering price of $14.00 per share, resulting in additional gross proceeds of approximately $1.6 million. After giving effect to this partial exercise of the overallotment option, the total number of shares sold by Bowman in its initial public offering increased to 3,805,925 shares and gross proceeds increased to approximately $53.3 million. The exercise of the over-allotment option closed on June 8, 2021, at which time the Company received net proceeds of approximately $1.5 million after underwriting discounts and commissions. See Initial Public Offering in Note 1 for further details.

On January 1, 2021 the Company entered into an agreement with a current employee that contained put options for 47,348 shares of common stock at $12.80 per share in increments of 7,021 shares quarterly, commencing on February 15, 2021. The option expired 90 days post-closing of an IPO. These shares were classified as common shares subject to repurchase on the condensed consolidated balance sheet as of March 31, 2021. On May 15, 2021, the employee exercised the option to redeem 1,800 shares. Based on the closing of the IPO, the option expires prior to August 15, 2021, and as such, no future option tranches may be exercised.